What improvements would you like in Yahoo! Finance Message Boards? Please send us feedback.
Insiders would have bought if H1N1 therapeutic showed prospects      7-Nov-09 09:50 pm    
With a global pandemic
DoD's charge to find a quick response platform for these viruses
and good old fashioned greed if the AVI PMO proved high efficacy
scaleability and affordability.
Hope I'm wrong but from my vantage point the only thing we have is the
PPMO trials begining in March and hope for sucess with the Marberg ,Junin and Ebola and they better produce better press
releases than the current PMO trials.
Gl2a.
Rating :
 (3 Ratings)
Rate it:
awful/not related to \pooraveragegoodexcellent

waterchain1

34/Female
Freemont


View Messages

Ignore User

Report Abuse

< Previous Message |   Next Message >
View: Simple | Summary | Expanded
As: Threaded | Msg List
Page 1 of about 1   First | < Prev | Next > | Last

Messages in Topic

Minimum rating: What's this?
  Subject Author Rating Time of Post (ET)  
 
Insiders would have bought if H1N1 therapeutic showed p...
waterchain1 7-Nov-09 09:50 pm  
 
they need to address the H1N1 program.. one way or...
jack_hemmer (2 Ratings) 8-Nov-09 04:58 pm  
 
H1N1 contract completion date was 11/3. We ma...
sensestable (2 Ratings) 8-Nov-09 05:18 pm  
 
Well the stock suggests there will not b...
conradfinkl... (1 Rating) 8-Nov-09 06:01 pm  
 
Why??? Because it's $1.45 per shar...
mjrruby2000... Rate it 8-Nov-09 06:03 pm  
View: Simple | Summary | Expanded
As: Threaded | Msg List
Page 1 of about 1   First | < Prev | Next > | Last

AVI Biopharma, Inc. (AVII)

Chart for AVI Biopharma, Inc. (AVII)
On Dec 7: 1.65 Down 0.01 (0.60%)
Symbol Lookup